Mobile-health Network Solutions Reports FY2026 Results, Highlights Investments in AI, Advances Ghana Expansion, and Launches MaNaDr Health Operating Ecosystem for Global Rollout
Gross margin expanded to 21.2% from 16.7%, while the annual net loss narrowed 9.7% to US$3.19 million.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Mobile-health Network Solutions (NASDAQ: MNDR) reported FY2026 revenue of approximately US$7.74 million, up 1.2% year over year.
For the year ended June 30, 2026, telemedicine revenue grew 3.9%, partly offset by lower medicine and medical device sales. Gross profit rose 28.3% to US$1.64 million, while gross margin reached 21.2%, versus 16.7% a year earlier. Net loss narrowed 9.7% to US$3.19 million; operating expenses increased 2.3%.
The company deployed proprietary healthcare AI technologies and advanced preparations for entry into Ghana with the Jospong Group. Services are expected to roll out progressively after implementation activities and local regulatory requirements are met. The MaNaDr Health Operating Ecosystem is scheduled to launch in Singapore on November 2, 2026, followed by a phased international rollout. Management expects the ecosystem to support future growth.
How this balance works
Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.
It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.
Rhea-AI Sentiment measures something else, the tone of the wording.
Hollow bars mark forward-looking points. How the balance works
Positive
- Major pointNet loss narrowed 9.7% year over year, though FY2026 still recorded a US$3.19 million loss.
- Moderate pointFY2026 revenue of approximately US$7.74 million increased 1.2% year over year.
- Moderate pointGross profit of US$1.64 million rose 28.3% year over year.
- Moderate pointGross margin reached 21.2%, compared with 16.7% in the prior year.
- Moderate pointTelemedicine revenue grew 3.9% in FY2026.
2 minor points
- Minor pointGhana expansion preparations advanced through collaboration with the Jospong Group.
- Minor point. Forward-looking: it has not happened yet and may not happen.Phased international ecosystem rollout is planned after the scheduled Singapore launch.
Negative
- Minor pointMedicine and medical device sales declined, partially offsetting FY2026 telemedicine growth.
- Minor pointOperating expenses increased 2.3% in FY2026.
- Minor pointGhana service rollout remains dependent on completing implementation activities and meeting local regulatory requirements.
Details
Market move: MNDR -3.18% vs previous close. FY2026 earnings report
On Oct 30, the day this news came out, the latest delayed price for MNDR is 3.18% below the previous close. Argus tracked a peak move of +19.2% during the session. Argus tracked a trough of -13.6% from its starting point during tracking. Our momentum scanner has recorded 34 alerts for this stock so far that day. The latest delayed price is $0.91. Relative volume is exceptionally heavy at 372.9x the average.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
- Revenue
- approximately US$7.74 million; up 1.2% year-over-year
- FY2026
- Gross profit
- US$1.64 million; up 28.3% year-over-year
- FY2026
- Gross margin
- 21.2% vs 16.7%
- FY2026 vs prior year
- Net loss
- US$3.19 million; narrowed by 9.7%
- FY2026 vs prior year
- Telemedicine segment
- grew by 3.9%
- FY2026 year-over-year
Key Terms
electronic medical record technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Singapore, Singapore--(Newsfile Corp. - October 30, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health ecosystem headquartered in Singapore, today announced its financial and operating results for the fiscal year ended June 30, 2026, highlighting the positive impact of its strategic investments in artificial intelligence, its expansion into Africa, and the continued development of new technology partnerships expected to support future growth.
FY2026 Financial Highlights
For FY2026, the Company reported revenue of approximately US
Gross profit increased by
The net loss narrowed to US
AI Investments Delivering Operational Benefits
Dr. Siaw Tung Yeng, Co-Chief Executive Officer and Chairman of MNDR, said: "Over the past year, we have invested significantly in artificial intelligence across our healthcare ecosystem. We are now seeing the benefits of these investments through improved operational efficiency, enhanced patient engagement, stronger platform capabilities, and a growing range of AI-enabled healthcare solutions. Our AI strategy is not only improving healthcare delivery but also strengthening the foundation for sustainable long-term growth."
The Company continued expanding its AI capabilities by deploying proprietary healthcare AI technologies, including AI-powered patient engagement and clinical support solutions integrated into the MaNaDr Health Operating System.
Ghana Expansion Progressing
MNDR has advanced its planned entry into Africa through its collaboration with the Jospong Group of Companies, one of Ghana's leading diversified business groups. The initiative will deploy MNDR's AI-powered digital healthcare platform in Ghana and establish a foundation for future expansion across the African continent.
The Company is undertaking the operational setup and preparatory activities required for market entry and expects to progressively roll out services after completing implementation activities and meeting local regulatory requirements. The initiative aims to improve healthcare accessibility and broaden adoption of digital healthcare services in Ghana.
Dr. Siaw Tung Yeng added: "Ghana represents an important strategic milestone in our international expansion journey. Through our partnership with the Jospong Group, we are laying the groundwork to introduce AI-powered healthcare solutions to a large and underserved market while creating a scalable platform for future growth across Africa."
MaNaDr Health Operating Ecosystem Positioned for Future Growth
The Company also highlighted the upcoming commercial rollout of the MaNaDr Health Operating Ecosystem, an integrated healthcare platform that connects virtual care, clinic management, electronic medical records, artificial intelligence technologies, patient engagement solutions, pharmacy services, and healthcare logistics into a single operating environment. The ecosystem is scheduled to launch initially in Singapore on November 2, 2026, followed by a phased international rollout.
Developed over more than two and a half years, the ecosystem combines MaNaDr's patient-facing healthcare platform with advanced clinic management and electronic medical record capabilities, enabling healthcare providers to seamlessly manage both virtual and in-person consultations while maintaining continuity of patient information throughout the patient journey.
The platform incorporates MNDR's proprietary artificial intelligence technologies, including Phi GPT for AI-assisted clinical documentation and Aiko, an AI healthcare companion designed to provide patient guidance, reminders, and ongoing support between consultations. Additional services such as pharmacy fulfillment, healthcare logistics, remote diagnostics, community engagement capabilities, and curated healthcare marketplace services further strengthen the platform's value proposition.
Management believes the MaNaDr Health Operating Ecosystem will become a key driver of future growth by providing a scalable technology foundation that enhances healthcare accessibility, improves patient engagement, supports healthcare providers, and facilitates the Company's expansion into new markets.
Outlook
Dr. Siaw Tung Yeng concluded: "As we look ahead, we remain focused on executing our AI-first growth strategy, expanding into new markets, and strengthening our ecosystem through strategic partnerships. We believe the continued advancement of our AI platform, the Ghana initiative, and the global rollout of the MaNaDr Health Operating Ecosystem will create meaningful opportunities for growth and value creation in the years ahead."
About Mobile-health Network Solutions
Mobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The Company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human through technology. For more information, please visit the Company's website.
Forward-Looking Statements
Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the Company's financial performance and business prospects, anticipated benefits of the Company's AI investments, Ghana expansion, and MaNaDr Health Operating Ecosystem, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.
For inquiries, please contact:
Mobile-health Network Solutions Investor Relations Contact:
2 Venture Drive, #07-08 Vision Exchange
Singapore 608526
Office: +65 6222 5223
Email: investors@manadr.com
Investor Relations Inquiries:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: ir@skylineccg.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/321777
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Mobile-health Network Solutions' FY2026 financial results?
Mobile-health Network Solutions reported approximately US$7.74 million in revenue and a US$3.19 million net loss for the fiscal year ended June 30, 2026. Revenue increased 1.2% year over year, while the net loss narrowed 9.7%. Gross profit increased 28.3% to US$1.64 million.
When will MNDR launch the MaNaDr Health Operating Ecosystem?
The MaNaDr Health Operating Ecosystem is scheduled to launch initially in Singapore on November 2, 2026, followed by a phased international rollout. The platform connects virtual care, clinic management, electronic medical records and related healthcare services in one operating environment.